Cormorant Global Healthcare Master Fund LP 13D and 13G filings for Edgewise Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 3:06 pm Sale | 2022-12-31 | 13G | Edgewise Therapeutics, Inc. EWTX | Cormorant Global Healthcare Master Fund LP | 2,946,887 4.660% | -619,014 (-17.36%) | Filing |
| 2022-02-14 3:13 pm Purchase | 2021-12-31 | 13G | Edgewise Therapeutics, Inc. EWTX | Cormorant Global Healthcare Master Fund LP | 3,565,901 7.230% | 974,987 (+37.63%) | Filing |
| 2021-05-18 4:08 pm Purchase | 2021-05-13 | 13G | Edgewise Therapeutics, Inc. EWTX | Cormorant Global Healthcare Master Fund LP | 2,590,914 5.260% | 2,590,914 (New Position) | Filing |